Live Breaking News & Updates on கேம்பிரிட்ஜ் கண்டறியும் இமேஜிங்
Stay updated with breaking news from கேம்பிரிட்ஜ் கண்டறியும் இமேஜிங். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Females in focus: The vaginal microbiome nutraingredients.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nutraingredients.com Daily Mail and Mail on Sunday newspapers.
Females in focus: The vaginal microbiome nutraingredients-usa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nutraingredients-usa.com Daily Mail and Mail on Sunday newspapers.
'State of Menopause' Study reveals what women in 2021 are experiencing nutraingredients.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nutraingredients.com Daily Mail and Mail on Sunday newspapers.
'State of Menopause' Study reveals what women in 2021 are experiencing nutraingredients-usa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nutraingredients-usa.com Daily Mail and Mail on Sunday newspapers.
Five firms swept up in FDA/FTC fertility claims enforcement action The enforcement action was announced yesterday. Warning letters were sent to the following five companies: “not amenable to self-diagnosis or treatment without the supervision of a licensed practitioner.” Range of disease/conditions mentioned Among the diseases or conditions that the five companies were allegedly claiming to treat are: Amenorrhea Apis mellifica (a homeopathic remedy derived from honey bees), ashwagandha, CoQ10 Viburnum opulus (rose) Dietary supplements that claim to cure, treat or prevent infertility and other reproductive health conditions can potentially harm consumers who use these products instead of seeking effective treatments, such as FDA-approved drugs or assisted reproductive technology,” said Judy McMeekin, Pharm.D., FDA’s Associate Commissioner for Regulatory Affairs. ....